BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.05, $0.23 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $10.47 million versus the consensus estimate of $88.3 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.